Insufficient scRNA-seq data for expression of USP50 at single-cell level.
Insufficient scRNA-seq data for expression of USP50 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 98% | 15.61 | 87 / 89 | 6% | 0.10 | 54 / 901 |
thymus | 97% | 11.04 | 634 / 653 | 6% | 0.07 | 34 / 605 |
bladder | 90% | 4.86 | 19 / 21 | 5% | 0.10 | 23 / 504 |
breast | 92% | 8.27 | 423 / 459 | 3% | 0.07 | 30 / 1118 |
liver | 93% | 11.31 | 211 / 226 | 1% | 0.01 | 3 / 406 |
adipose | 93% | 8.93 | 1116 / 1204 | 0% | 0 | 0 / 0 |
prostate | 88% | 6.13 | 216 / 245 | 1% | 0.02 | 6 / 502 |
spleen | 89% | 5.56 | 215 / 241 | 0% | 0 | 0 / 0 |
lung | 81% | 4.79 | 471 / 578 | 7% | 0.14 | 80 / 1155 |
esophagus | 61% | 2.74 | 888 / 1445 | 26% | 0.35 | 47 / 183 |
skin | 84% | 6.86 | 1525 / 1809 | 3% | 0.04 | 13 / 472 |
ovary | 77% | 3.92 | 138 / 180 | 3% | 0.03 | 11 / 430 |
adrenal gland | 74% | 3.69 | 190 / 258 | 1% | 0.01 | 2 / 230 |
uterus | 73% | 3.59 | 124 / 170 | 1% | 0.03 | 5 / 459 |
intestine | 68% | 3.26 | 658 / 966 | 4% | 0.06 | 21 / 527 |
blood vessel | 69% | 3.49 | 915 / 1335 | 0% | 0 | 0 / 0 |
heart | 67% | 3.06 | 573 / 861 | 0% | 0 | 0 / 0 |
stomach | 54% | 2.11 | 195 / 359 | 6% | 0.13 | 18 / 286 |
brain | 60% | 3.07 | 1573 / 2642 | 1% | 0.01 | 4 / 705 |
pancreas | 53% | 2.02 | 174 / 328 | 3% | 0.06 | 6 / 178 |
muscle | 43% | 1.65 | 343 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 31% | 0.95 | 288 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1902749 | Biological process | regulation of cell cycle G2/M phase transition |
GO_0071108 | Biological process | protein K48-linked deubiquitination |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_0035063 | Biological process | nuclear speck organization |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_1900227 | Biological process | positive regulation of NLRP3 inflammasome complex assembly |
GO_0032741 | Biological process | positive regulation of interleukin-18 production |
GO_0070536 | Biological process | protein K63-linked deubiquitination |
GO_2001056 | Biological process | positive regulation of cysteine-type endopeptidase activity |
GO_0007032 | Biological process | endosome organization |
GO_0016579 | Biological process | protein deubiquitination |
GO_0030496 | Cellular component | midbody |
GO_0043197 | Cellular component | dendritic spine |
GO_0005813 | Cellular component | centrosome |
GO_0005829 | Cellular component | cytosol |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
GO_0019783 | Molecular function | ubiquitin-like protein peptidase activity |
Gene name | USP50 |
Protein name | Ubiquitin specific peptidase 50 Alternative protein USP50 Ubiquitin carboxyl-terminal hydrolase 50 (EC 3.4.19.12) (Ubiquitin-specific peptidase 50) |
Synonyms | |
Description | FUNCTION: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes. Regulates the inflammasome signaling pathway by deubiquitinating 'Lys-63'-linked polyubiquitination of the PYCARD/ASC adapter protein . Regulates the ubiquitination and stability of the ACE2 protein . Acts as a negative regulator of the G2/M checkpoint pathway, by preventing serine/threonine kinase WEE1 degradation, thereby repressing entry into mitosis following activation of the G2/M DNA damage checkpoint . . |
Accessions | L8EBI2 H0YDN5 ENST00000616326.1 ENST00000559105.5 ENST00000529349.2 ENST00000673895.1 H0YNB9 Q70EL3 A0A669KB43 ENST00000532404.6 [Q70EL3-2] A0A087X0L6 |